Make saxenda available to more people on the hse drugs payment scheme


Make saxenda available to more people on the hse drugs payment scheme
The Issue
Liraglutide (also called Saxenda) is a weight loss medicine that works by making you feel fuller and less hungry. It's taken as an injection once a day.
Saxenda has been approved under the drugs payment scheme in Ireland but under very strict conditions:
Age 18 - 74 years
BMI ≥ 35 kg/m2
Confirmation of:
o participation in non-pharmacological interventions which includes a reduced-calorie diet
and increased physical activity e.g. HSE Diabetes Prevention Programme*
o diagnosis of prediabetes - fasting plasma glucose level between 5.5 - 6.9 mmol/L and
HbA1c level between 42 - 47 mmol/mol
o high risk of CVD - total fasting cholesterol level > 5 mmol/L, or mean systolic blood
pressure (BP) > 140 mmHg, despite pharmacological treatment
This petition is about making the drug available to more people with a bmi over 30 before they suffer side effects like high blood pressure, high cholesterol and diabetes.
The drug is currently available privately to those with a bmi of over 30 but with a price of circa €240 per month this means many people who could benefit from it cannot afford it.

223
The Issue
Liraglutide (also called Saxenda) is a weight loss medicine that works by making you feel fuller and less hungry. It's taken as an injection once a day.
Saxenda has been approved under the drugs payment scheme in Ireland but under very strict conditions:
Age 18 - 74 years
BMI ≥ 35 kg/m2
Confirmation of:
o participation in non-pharmacological interventions which includes a reduced-calorie diet
and increased physical activity e.g. HSE Diabetes Prevention Programme*
o diagnosis of prediabetes - fasting plasma glucose level between 5.5 - 6.9 mmol/L and
HbA1c level between 42 - 47 mmol/mol
o high risk of CVD - total fasting cholesterol level > 5 mmol/L, or mean systolic blood
pressure (BP) > 140 mmHg, despite pharmacological treatment
This petition is about making the drug available to more people with a bmi over 30 before they suffer side effects like high blood pressure, high cholesterol and diabetes.
The drug is currently available privately to those with a bmi of over 30 but with a price of circa €240 per month this means many people who could benefit from it cannot afford it.

223
The Decision Makers
Petition created on 30 March 2023